Biotech Perspectives
Perspectives and best practices from the world of healthcare and life sciences.
Our latest ideas
Collected wisdom from 15+ years working with pharma and biotechs. We share our point of view on patient experience, rare and complex disease, and communication best practices.
Collected wisdom from 15+ years working with pharma and biotechs. We share our point of view on patient experience, rare and complex disease, and communication best practices.
On journey mapping
Moving beyond customer-centricity theatre. An in-depth breakdown of journey maps and how to use them correctly.
The case for early investment in rare disease state education
An examination of reasons why disease state education for rare diseases helps patients better navigate their journey and complex decisions.
5 tips for safely using LLMs to get medical advice
Examining issues with using LLMs to gather health information, and tips for having useful and less risky conversation with LLMs.
A new approach to clinical trials
A look a how Bayesian analytics could open the doors to cheaper and faster clinical trials
Why building awareness for rare disease clinical trials matters
A framework that can help us better measure patient experience, and allow organizations to continually learn, grow, and implement changes both small and large to improve patients’ experiences.
Improving patient experience: a multidimensional measurement framework
A framework that can help us better measure patient experience, and allow organizations to continually learn, grow, and implement changes both small and large to improve patients’ experiences.
Lessons from the Sepsis Watch rollout
Delving into an example of new disruptive technology being successfully integrated into a healthcare setting.
Improving accessibility
An exploration of the four primary principles we follow for improving accessibility of patient resources.
The participation problem: addressing socioeconomic barriers in clinical trials
Examining the structural and economic barriers that impact patient participation in clinical trials, and our approach to the problem.
Women’s representation in clinical research
An examination of the gap in understanding women’s health by looking back at women’s representation in clinical research over time.
Form design 101
A look at the experience of using and designing a form – an integral step to providing care that shapes the overall patient experience.
Hybrid co-creation in pharma and biotech
An examination of how bringing internal participants together for a hybrid co-creation creates shared intentions and speed to market.
Informed consent in healthcare: adding to FDA guidance
A look at best practices in patient communication that may help comply with FDA guidance on informed consent, as well as practical tips.
HCP communication best practices
A deep dive into the three best practices we follow to create HCP communications that are more focused, trustworthy, and multipurpose.
Patient-centred communications in pharma and biotech
An examination of the Universal Patient Language (UPL) as an example of how a pharma company can create effective patient communications.
Treatment decision-making: a Framework
A look at our best practices for developing clear, credible, and high-impact communication materials to be used by HCPs.
On journey mapping
Moving beyond customer-centricity theatre. An in-depth breakdown of journey maps and how to use them correctly.
The case for early investment in rare disease state education
An examination of reasons why disease state education for rare diseases helps patients better navigate their journey and complex decisions.
5 tips for safely using LLMs to get medical advice
Examining issues with using LLMs to gather health information, and tips for having useful and less risky conversation with LLMs.
A new approach to clinical trials
A look a how Bayesian analytics could open the doors to cheaper and faster clinical trials
Why building awareness for rare disease clinical trials matters
A framework that can help us better measure patient experience, and allow organizations to continually learn, grow, and implement changes both small and large to improve patients’ experiences.
Improving patient experience: a multidimensional measurement framework
A framework that can help us better measure patient experience, and allow organizations to continually learn, grow, and implement changes both small and large to improve patients’ experiences.
Lessons from the Sepsis Watch rollout
Delving into an example of new disruptive technology being successfully integrated into a healthcare setting.
Improving accessibility
An exploration of the four primary principles we follow for improving accessibility of patient resources.
The participation problem: addressing socioeconomic barriers in clinical trials
Examining the structural and economic barriers that impact patient participation in clinical trials, and our approach to the problem.
Women’s representation in clinical research
An examination of the gap in understanding women’s health by looking back at women’s representation in clinical research over time.
Form design 101
A look at the experience of using and designing a form – an integral step to providing care that shapes the overall patient experience.
Hybrid co-creation in pharma and biotech
An examination of how bringing internal participants together for a hybrid co-creation creates shared intentions and speed to market.
Informed consent in healthcare: adding to FDA guidance
A look at best practices in patient communication that may help comply with FDA guidance on informed consent, as well as practical tips.
HCP communication best practices
A deep dive into the three best practices we follow to create HCP communications that are more focused, trustworthy, and multipurpose.
Patient-centred communications in pharma and biotech
An examination of the Universal Patient Language (UPL) as an example of how a pharma company can create effective patient communications.
Treatment decision-making: a Framework
A look at our best practices for developing clear, credible, and high-impact communication materials to be used by HCPs.
Stay in touch
Follow us on LinkedIn for regular updates.
We always love to collaborate with like-minded people.
If you’re passionate about patient experience, say hello@workomics.com